Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Boxer and Labrador dogs' hair growth is affected by the tropical climate, but Schnauzers' is not.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The paper suggests that hair loss might be caused by skull growth, not just DHT's effect on hair follicles, and calls for more research.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Finasteride helps reduce heart enlargement in heart failure patients.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Key genes can rewire networks, changing skin appendage types.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Finasteride, often used for hair loss, can potentially cause cataracts.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.